The present invention relates to an adhesive composition comprising a. a polyethylene resin (A) which has been grafted with an acid grafting agent and b. an epoxy resin (B) in an amount of 0.01 to 15 wt. % of the adhesive total composition, wherein the adhesive composition is having a MFR.sub.5 of 0.1 to 12 g/10 min. Furthermore, the invention relates to an article, in particular a multilayer pipe, comprising an adhesive layer which comprises said adhesive composition and the use of said adhesive composition for the production of an adhesive layer, in particular of an adhesive layer of a pipe.

The present invention relates to a resin film for a flexible printed circuit board consisting of a resin composition containing: a long-chain alkyl bismaleimide resin having a main chain containing an alkylene chain having 10 or more carbon atoms and a side chain containing an alkyl group bonded to the alkylene chain; and a curing agent having two or more functional groups reacting with the long-chain alkyl bismaleimide resin.

A water dispersion of gel particles, in which the gel particles having a polymerizable group, having a three-dimensional crosslinked structure including at least one bond selected from a urethane bond and a urea bond, and including at least a photopolymerization initiator and a resin are dispersed in water, a method of producing the water dispersion, and an image forming method using the water dispersion.

A foundry mix includes a major amount of a foundry aggregate and an effective binding amount of a binder system. The binder system cures in the presence of sulfur dioxide and a free radical initiator. The binder system may include (1) 10 to 70 parts by weight of an epoxy novolac resin; (2) 0.5 to 10 parts by weight of resorcinol; (3) 20 to 70 parts by weight of a monomeric or polymeric acrylate; and (4) an effective amount of a free radical initiator. Notably, (1), (2), (3) and (4) are separate components or mixed with another of said components, provided (4) is not mixed with (3) until a foundry mix is to be created, where said parts by weight are based upon 100 parts of the binder system.

Polymeric compositions are provided that include a poly(ethylene glycol), a viscoelastic polymer, and an antioxidant, where, in polymerized form, the compositions have a refractive index of about 1.30 to about 1.40. Methods of synthesizing the compositions are also provided and include the steps of heating an amount of water; adding a buffering agent to the water to form a buffer solution; mixing a poly(ethylene glycol) and a viscoelastic polymer into the buffer solution to form a reactive mixture; adding a plurality of antioxidant particles to the reactive mixture; and removing suspended gas bubbles from the reactive mixture. Methods of preventing oxidative damage to an eye lens of a subject are further provided and include administering the foregoing polymeric compositions to the eye lens of the subject.

Embodiments of polyethylene formulations and articles comprising polyethylene formulations are disclosed. The polyethylene formulation may include from 45 wt. % to 90 wt. % of an MDPE having a density of from 0.930 g/cc to 0.950 g/cc and a melt index (I.sub.2) from 0.05 g/10 min to 0.5 g/10 min; from 10 wt. % to 50 wt. % of a polyethylene composition having a density from 0.910 g/cc to 0.936 g/cc and a melt index (I.sub.2) from 0.7 g/10 min to 1.0 g/10 min; and from 0.5 wt. % to 5% of a masterbatch composition. The polyethylene composition may comprise a first polyethylene fraction area in a temperature range of 45° C. to 87° C. of an elution profile via improved comonomer composition distribution (iCCD) analysis method and a second polyethylene fraction area in a temperature range of 95° C. to 120° C. of an elution profile via iCCD.

The present disclosure provides copolymers useful in medical devices. For example, the disclosure provides copolymers comprising the polymerization product ester block, ether blocks and diisocyanates. In certain embodiments, the disclosure provides a medical copolymer for implantation comprising ester blocks and ether blocks, wherein: the ester blocks comprise a negative free energy transfer and the ether blocks comprise a positive free energy transfer, the ether and ester blocks are less than 1/10 the length of said copolymer, and, the blocks are distributed such that no domain of contiguous blocks possessing the same polarity of free energy transfer are less than ⅓ of the molecular weight of the copolymer. The disclosure further provides methods of making the aforementioned polymers, and medical devices comprising the polymers.

Through the present invention, by undergoing a step in which a straight-chain diorganopolysiloxane having silanol groups at both terminal ends of the molecular chain thereof, a hydrolyzable silane and/or a partial hydrolysis condensate thereof having a hydrolyzable group capable of detaching a lactic acid ester, and an amino-group-containing hydrolyzable organosilane and/or a partial hydrolysis condensate thereof are pre-mixed/reacted in advance and silanol groups at both terminal ends of the molecular chain of a main agent (base polymer) are blocked by specific hydrolyzable silyl groups, it is possible to manufacture a lactic-acid-ester-type room-temperature-curable organopolysiloxane composition excellent in all characteristics including curability, adhesive properties, workability, and the like that were not attainable by the conventional lactic-acid-ester-type room-temperature curable (RTV) silicone rubber composition.

This document provides hemp fiber biocomposites and methods and materials for making and using hemp fiber biocomposites. For example, hemp fiber biocomposites that can be used as a hydroponic growth medium are provided. Methods for making hemp fiber biocomposites also are provided.

Through the present invention, by undergoing a step in which a straight-chain diorganopolysiloxane having silanol groups at both terminal ends of the molecular chain thereof, a hydrolyzable silane and/or a partial hydrolysis condensate thereof having a hydrolyzable group capable of detaching a lactic acid ester, and an amino-group-containing hydrolyzable organosilane and/or a partial hydrolysis condensate thereof are pre-mixed/reacted in advance and silanol groups at both terminal ends of the molecular chain of a main agent (base polymer) are blocked by specific hydrolyzable silyl groups, it is possible to manufacture a lactic-acid-ester-type room-temperature-curable organopolysiloxane composition excellent in all characteristics including curability, adhesive properties, workability, and the like that were not attainable by the conventional lactic-acid-ester-type room-temperature curable (RTV) silicone rubber composition.